Evidence map›Paper›PMID 22412059›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2012

Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.

Carolyn D Alonso, Suzanne B Treadway, David B Hanna, Carol Ann Huff, Dionissios Neofytos, Karen C Carroll, Kieren A Marr

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 4 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 4 syntheses or guidelines pooled it, 204 citations in OpenAlex.

  1. Pooled it
  2. Prevalence ofFrontiers in cellular and infection microbiology · 2022
    Pooled it
  3. Guideline
  4. The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2016
    Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Derivation and validation of a prediction model for primary and recurrentAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  9. Article
  10. Management ofEClinicalMedicine · 2025
    Review
  11. CONCURRENTActa clinica Croatica · 2025
    Article
  12. Article
  13. Epidemiology and Outcomes of RecurrentOpen forum infectious diseases · 2024
    Article
  14. Clinical microbiology reviews · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Fecal Microbiota Transplantation forIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Carolyn D AlonsoDepartment of Medicine, The Johns Hopkins Hospital, Baltimore, MD 21205, USA.
Suzanne B Treadway
David B Hanna
Carol Ann Huff
Dionissios Neofytos
Karen C Carroll
Kieren A Marr
Johns Hopkins Hospital · USJohns Hopkins University · US

Funding

RESEARCH TRAINING IN MICROBIAL DISEASEST32AI007291 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JOEL N BLANKSON, Sara Elizabeth Cosgrove · 1986 to 2026
$9.1M
Patient Oriented Research in Transplant and Oncology IDK24AI085118 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MARR, KIEREN A. · 2010 to 2014
$995k
NIAID NIH HHS K24 AI085118NIAID NIH HHS T32 AI007291
6 · The paper itself

Abstract

Background. Clostridium difficile is the leading cause of infectious diarrhea among hospitalized patients and is a major concern for patients undergoing hematopoietic stem cell transplantation (HSCT). Risk factors and the natural history of C. difficile infection (CDI) are poorly understood in this population. Methods. We performed a retrospective nested case-control study to describe the epidemiology, timing, and risk factors for CDI among adult patients who received HSCTs at our center from January 2003 through December 2008. Results. The overall 1-year incidence of CDI was 9.2% among HSCTs performed (n = 999). The median time to diagnosis of CDI was short among both autologous and allogeneic HSCT recipients (6.5 days and 33 days, respectively). Risk factors for CDI in allogeneic HSCT recipients included receipt of chemotherapy prior to conditioning for HSCT, broad-spectrum antimicrobial use, and acute graft-versus-host disease (GVHD; adjusted odds ratio [AOR], 4.45; 95% confidence interval [CI], 1.54-12.84; P = .006). There was a strong relationship between early CDI and subsequent development of gastrointestinal tract GVHD in the year following allogeneic HSCT (P < .001). Gastrointestinal GVHD was also strongly associated with an increased risk for recurrent CDI (AOR, 4.23 [95% CI, 1.20-14.86]; P = .02). Conclusions. These results highlight the high incidence and early timing of CDI after HSCT. Early timing, coupled with the noted risk of pretransplant chemotherapy, suggests that the natural history of disease in some patients may involve colonization prior to HSCT. A potentially important interplay between CDI and GVHD involving the gastrointestinal tract was observed.

Indexed as

AdultCase-Control StudiesClostridioides difficileClostridium InfectionsCross InfectionFemaleHematopoietic Stem Cell TransplantationHumansIncidenceMaleMiddle AgedRetrospective StudiesRisk FactorsTime FactorsTreatment Outcome

Identifiers

PMID22412059
PMCPMC3309884
OpenAlexW2158434543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.